Mahmud A M, Teshima T, Isawa T, Miki M, Horikoshi M, Yanagimachi T, Nukiwa T
Department of Respiratory Oncology and Molecular Medicine, Tohoku University, Sendai, Japan.
Nucl Med Commun. 1998 May;19(5):417-26. doi: 10.1097/00006231-199805000-00003.
In addition to imaging, radionuclide venography can be used for studying haemodynamic changes in superior vena cava syndrome (SVCS) by using the indices of transit time (TT), time of half peak count (TH) and peak count ratio (PC ratio). The objective of this study was to examine the utility of applying these indices, alongside images, in the post-therapy assessment of SVCS patients. Radionuclide venography was performed twice on 36 patients with SVCS due to thoracic malignancies, 29 of whom received specific anti-cancer therapy between the two studies (Group I); the other 7 did not receive such therapy (Group II). On the images, 12 patients in Group I showed improvement, one a deterioration and 16 no change; in Group II, 4 showed a deterioration and 3 no change. Using the indices, nearly all patients in Group I had decreased post-therapy values indicating haemodynamic improvement. A significant difference was seen between the mean (+/- S.E.) pre- and post-therapy values for TT (pre vs post: 6.2 +/- 0.7 vs 2.7 +/- 0.3 s) and TH (pre vs post: 16.9 +/- 2.3 vs 7.9 +/- 0.8 s) (P < 0.001). Although the PC ratio showed a non-significant decrement, it related to the status of collateral change. The above indices provide clinically valuable information about the haemodynamic status of patients with SVCS and can be used for their post-therapy evaluation.
除影像学检查外,放射性核素静脉造影可通过使用通过时间(TT)、半峰值计数时间(TH)和峰值计数比(PC比)等指标来研究上腔静脉综合征(SVCS)的血流动力学变化。本研究的目的是检验在SVCS患者的治疗后评估中应用这些指标并结合图像的效用。对36例因胸部恶性肿瘤导致SVCS的患者进行了两次放射性核素静脉造影,其中29例在两次检查之间接受了特异性抗癌治疗(I组);另外7例未接受此类治疗(II组)。在图像上,I组12例患者显示改善,1例恶化,16例无变化;II组中,4例恶化,3例无变化。使用这些指标,I组几乎所有患者治疗后的值均降低,表明血流动力学改善。TT(治疗前与治疗后:6.2±0.7 vs 2.7±0.3秒)和TH(治疗前与治疗后:16.9±2.3 vs 7.9±0.8秒)的治疗前和治疗后平均(±标准误)值之间存在显著差异(P<0.001)。尽管PC比显示出不显著的下降,但它与侧支循环变化的状态有关。上述指标提供了关于SVCS患者血流动力学状态的临床有价值信息,可用于他们的治疗后评估。